hybrid FSP/FSO

R&D

Biotech and pharma companies increasingly require additional agility, flexibility, and operational efficiency in their clinical research operations.

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.